Sunshine Biopharma Inc.

09/13/2012 | Press release | Archived content

SUNSHINE BIOPHARMA ADVANCES TO NEXT PHASE OF DRUG DEVELOPMENT WITH LEAD ANTI CANCER COMPOUND, ADVA 27A